drugset / Trial / NCT05041920

A Drug-drug Interaction Study of Famitinib Malate With a Proton Pump Inhibitor in Healthy Adult Subjects

NCT05041920

Phase 1 Completed 20 enrolled Jiangsu HengRui Medicine Co., Ltd.
NaSingle-groupOpen-labelBasic science

Summary

The primary objective is to evaluate the effect of omeprazole on the pharmacokinetics of famitinib malate in healthy adult subjects. The secondary objective is to evaluate the safety after famitinib malate alone or combined administration with omeprazole in healthy adult subjects.

Timeline

Start
2021-09-07
Primary completion
2021-10-06
Completion
2021-10-27

Drugs

EvaluationDrugModalityDoseRoute
Subject Famitinib Small molecule 25 mg
Subject Omeprazole Other / unclassified 40 mg

Indications